skip to main content

Yellow Card reporting — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyAdverse Drug Reactions and SafetyYellow Card reportingGPhC CRA

A patient reports a suspected severe rash and facial swelling after starting lamotrigine two weeks ago. He recovered after attending urgent care and asks whether the pharmacy can report it. What would you advise the patient?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Submit a Yellow Card report and advise urgent medical review if symptoms recur

Suspected serious adverse drug reactions should be reported through the Yellow Card scheme. Lamotrigine can cause severe skin reactions, so recurrence symptoms need urgent medical assessment. Causality does not need to be proven before reporting. Rechallenge would be unsafe and outside pharmacy practice.

Reference: BNF; MHRA Yellow Card